scPharmaceuticals Inc (NASDAQ:SCPH) has a beta value of 0.37 and has seen 0.43 million shares traded in the recent trading session. The company, currently valued at $117.67M, closed the recent trade at $2.34 per share which meant it lost -$0.29 on the day or -11.02% during that session. The SCPH stock price is -141.45% off its 52-week high price of $5.65 and -6.84% below the 52-week low of $2.50. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.44 million shares traded. The 3-month trading volume is 406.66K shares.
The consensus among analysts is that scPharmaceuticals Inc (SCPH) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
scPharmaceuticals Inc (NASDAQ:SCPH) trade information
Sporting -11.02% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the SCPH stock price touched $2.34 or saw a rise of 24.03%. Year-to-date, scPharmaceuticals Inc shares have moved -33.90%, while the 5-day performance has seen it change -22.00%. Over the past 30 days, the shares of scPharmaceuticals Inc (NASDAQ:SCPH) have changed -27.10%. Short interest in the company has seen 5.67 million shares shorted with days to cover at 9.55.
Wall Street analysts have a consensus price target for the stock at $13, which means that the shares’ value could jump 82.0% from the levels at last check today. The projected low price target is $13.0 while the price target rests at a high of $13.0. In that case, then, we find that the latest price level in today’s session is -455.56% off the targeted high while a plunge would see the stock gain -455.56% from the levels at last check today.
scPharmaceuticals Inc (SCPH) estimates and forecasts
The company’s shares have lost -49.24% over the past 6 months. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -1.52% over the past 5 years.
SCPH Dividends
scPharmaceuticals Inc is expected to release its next earnings report on 2025-Mar-18 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
scPharmaceuticals Inc (NASDAQ:SCPH)’s Major holders
Insiders own 11.16% of the company shares, while shares held by institutions stand at 84.89% with a share float percentage of 95.56%. Investors are also buoyed by the number of investors in a company, with scPharmaceuticals Inc having a total of 114.0 institutions that hold shares in the company. The top two institutional holders are ORBIMED ADVISORS LLC with over 5.56 million shares worth more than $24.18 million. As of 2024-06-30, ORBIMED ADVISORS LLC held 14.2608% of shares outstanding.
The other major institutional holder is RUBRIC CAPITAL MANAGEMENT LP, with the holding of over 3.52 million shares as of 2024-06-30. The firm’s total holdings are worth over $15.33 million and represent 9.042% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. As of Dec 31, 2024, the former fund manager holds about 2.26% shares in the company for having 1.14 shares of worth $2.67 million while later fund manager owns 854.33 shares of worth $2.0 million as of Feb 28, 2025, which makes it owner of about 1.70% of company’s outstanding stock.
